David Stump, M.D., ’72 served as executive vice president for research and development at Human Genome Sciences from 1999 until 2012. From 1995 to 1999, he served as vice president of clinical research and Genentech Fellow at Genentech. He first joined Genentech in 1989 as director of clinical research and leader of its thrombolytic therapy drug development program. Prior to joining Genentech, he was an associate professor of medicine and biochemistry at the University of Vermont. He received his medical degree at Indiana University and his postgraduate training at the University of Iowa and University of Leuven, Belgium. He is board certified in internal medicine, hematology and medical oncology and is a fellow of the American College of Physicians and the Council on Arteriosclerosis, Thrombosis and Vascular Biology of the American Heart Association. He is the author of approximately 60 scientific publications and is a member of the board of directors of Sunesis Pharmaceuticals, MacroGenics, Portola Pharmaceuticals, and Regenxbio. His late wife Carolyn Sorrows Stump ’71 served on the Alumni Council for nine years. David has served the Board for 12 years, 9 years as chair of its Academic Affairs Committee and most recently 2 years as board chair.